Reduction of ASHG/TLR4/JNK/NF-κB pathway activation exerts a protective effect against inflammation and obesity as well as liver-related insulin resistance [62]. The gene discussed is NFKB1; the disease is obesity due to melanocortin 4 receptor deficiency.